Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.84B | $3.14B | $3.42B | $3.74B | $3.92B | $4.30B | $4.68B | $5.20B |
| Cost of revenue | $2.28B | $2.50B | $2.72B | $3.14B | $3.46B | $4.02B | $4.77B | $5.21B |
| Gross profit | $556.6M | $637.3M | $701.9M | $597.8M | $459.7M | $277.7M | −$91.4M | −$11.3M |
| Gross margin | 19.6% | 20.3% | 20.5% | 16.0% | 11.7% | 6.5% | -2.0% | -0.2% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $348.1M | $394.4M | $427.7M | $502.9M | $426.4M | $364.6M | −$664.3M | $5.20B |
| EBITDA | $504.9M | $396.4M | $586.3M | $958.7M | $901.9M | $971.6M | −$3.45B | $2.65B |
| Net income | $256.4M | $89.8M | $220.4M | $234.0M | $160.0M | $65.2M | −$4.03B | $1.35B |
| Net margin | 9.0% | 2.9% | 6.4% | 6.3% | 4.1% | 1.5% | -86.0% | 26.1% |
| EPS (diluted) | 212.85 | 72.90 | 170.63 | 174.72 | 117.17 | 47.68 | -3116.52 | 652.97 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds ORRRY.
No tracked institution reports a position in ORRRY as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2024-04-15 | $0.0020 |
No one on the platform has traded ORRRY yet.
| $281M |
| — |
| HYBTHeyu Biological Technology Corporation | $0.35 | -41.67% | $361M | — |
| PEXXFPT Tempo Scan Pacific Tbk | $0.09 | +0.00% | $463M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.